
The Expanding Therapeutic Landscape of GLP-1 Receptor Agonists: Beyond Glycemic Control and Weight Management
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized the treatment of type 2 diabetes mellitus (T2DM) and obesity, demonstrating superior glycemic control and substantial weight loss compared to traditional therapies. These effects stem from […]